1. Circulating TP53 Mutations Are Predictive and Prognostic Biomarkers in Pancreatic Cancer Patients Treated with FOLFIRINOX Chemotherapy. (2021) Authors: van der Sijde, F.; Besselink, M.; de Groot, J.W.; Haberkorn, B.; Homs, M.; Luelmo, S.; Mekenkamp, L.; Mustafa, D.; Wilmink, J.; van Eijck, C.; Vietsch, E. Journal: HPB Issue: Volume 23(2021)Supplement 3 Page Start: S681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗